BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8901281)

  • 1. [Has drug treatment of manic disorders changed in clinical routine practice? Retrospective analysis of treatment modalities and results in a university psychiatric clinic].
    Reetz-Kokott U; Müller-Oerlinghausen B
    Nervenarzt; 1996 Mar; 67(3):229-34. PubMed ID: 8901281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [General practice of acute inpatient treatment of mania. Retrospective comparative study of 100 patients at each of 2 psychiatric centers].
    Adler L; Ulrich M; Lehmann K; Nordeck I; Langer C; Thomas RS; Hajak G; Koller M
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):479-88. PubMed ID: 7835819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
    Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
    J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics.
    Reischies FM; Hartikainen J; Berghöfer AM
    Pharmacopsychiatry; 2002 Nov; 35(6):244-6. PubMed ID: 12518274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.
    Wolfsperger M; Greil W; Rössler W; Grohmann R
    J Affect Disord; 2007 Apr; 99(1-3):9-17. PubMed ID: 16989907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Valproate in the treatment of bipolar disorder].
    Rzewuska M
    Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision model for the acute treatment of mania.
    Steffens DC; Krishnan KR
    Depress Anxiety; 1996-1997; 4(6):289-93. PubMed ID: 9166657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium neurotoxicity at low therapeutic doses Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports.
    Emilien G; Maloteaux JM
    Acta Neurol Belg; 1996 Dec; 96(4):281-93. PubMed ID: 9008777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-economic implications of the onset of action of antimanic agents.
    Keck PE; McElroy SL; Bennett JA
    J Clin Psychiatry; 1996; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antipsychotic drugs and lithium in mania.
    Cookson J
    Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in treatment of acute mania.
    Chou JC
    J Clin Psychopharmacol; 1991 Feb; 11(1):3-21. PubMed ID: 1674948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of neuroleptics in manic-depressive illness.
    Kane JM
    J Clin Psychiatry; 1988 Nov; 49 Suppl():12-4. PubMed ID: 2903142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive treatment of acute mania: a clinical overview.
    Sachs GS; Gardner-Schuster EE
    Acta Psychiatr Scand Suppl; 2007; (434):27-34. PubMed ID: 17688460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.